1. Home
  2. CRAI vs PHAT Comparison

CRAI vs PHAT Comparison

Compare CRAI & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRA International Inc.

CRAI

CRA International Inc.

HOLD

Current Price

$188.22

Market Cap

1.2B

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$14.64

Market Cap

942.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRAI
PHAT
Founded
1965
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
942.6M
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
CRAI
PHAT
Price
$188.22
$14.64
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$239.00
$17.60
AVG Volume (30 Days)
76.1K
825.0K
Earning Date
10-30-2025
10-30-2025
Dividend Yield
1.04%
N/A
EPS Growth
34.79
N/A
EPS
8.34
N/A
Revenue
$731,055,000.00
$147,190,000.00
Revenue This Year
$10.26
$218.38
Revenue Next Year
$3.48
$87.14
P/E Ratio
$22.65
N/A
Revenue Growth
8.69
460.30
52 Week Low
$152.57
$2.21
52 Week High
$214.66
$16.27

Technical Indicators

Market Signals
Indicator
CRAI
PHAT
Relative Strength Index (RSI) 59.52 55.02
Support Level $175.15 $14.61
Resistance Level $178.74 $16.27
Average True Range (ATR) 5.79 0.81
MACD 1.37 -0.06
Stochastic Oscillator 91.11 28.70

Price Performance

Historical Comparison
CRAI
PHAT

About CRAI CRA International Inc.

CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: